Your health and safety remain our top priority: Learn about our Safe Care Commitment | Use our Prescreen app before arrival for faster entry | Read the COVID-19 Vaccine FAQs
Header Skipped.
The Brigham’s 7T MRI unit, just the second in the country to be approved for clinical use, revealed that a potential biomarker of brain inflammation in patients affected by multiple sclerosis is more common than previously thought.
The 16-hour surgery, involving a team of over 45 surgeons, nurses, anesthesiologists, residents and research fellows, and led by Bohdan Pomahac, MD, was the ninth face transplant procedure at the Brigham and the 15th nationwide.
Brigham rheumatologist has long history of innovative leadership in patient care and safety Read More...
In a large-scale clinical trial, researchers from the Brigham found that dapagliflozin, an SGLT2 inhibitor, reduced the risk of cardiovascular death or worsening heart failure irrespective of ejection fraction; A meta-analysis also presented by Br Read More...
Researchers evaluated clinicians' use of an artificial intelligence (AI) model that can identify tumors, finding that physician-AI teams may improve clinical workflow by reducing treatment planning time and improving consistency Read More...
